Sign in with Google

ENTITY

SMARTSCORE: 3.6/5

Yichang HEC Changjiang Pharma (1558 HK)

86

Analysis

Health Care • Hong Kong

YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs. The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.

more

Refresh

Exchange Announcement • 28 Mar 2025 14:51

Annual Results Announcement For The Year Ended 31 December 2024

Exchange Announcement • 27 Mar 2025 13:00

Voluntary Announcement Encofosbuvir Tablets (0.3g) Approved For Launch

Exchange Announcement • 18 Mar 2025 11:31

Notice Of Board Meeting

Exchange Announcement • 10 Mar 2025 13:00

Joint Announcement Monthly Update In Relation To The Proposed Pre-Conditional Privatisation Of Yichang Hec Changjiang Pharmaceutical Co., Ltd. By Sunshine Lake Pharma Co., Ltd. By Way Of Merger By Absorption Of Yichang Hec Changjiang Pharmaceutical Co., Ltd.

Exchange Announcement • 10 Feb 2025 13:02

Joint Announcement Monthly Update In Relation To The Proposed Pre-Conditional Privatisation Of Yichang Hec Changjiang Pharmaceutical Co., Ltd. By Sunshine Lake Pharma Co., Ltd. By Way Of Merger By Absorption Of Yichang Hec Changjiang Pharmaceutical Co., Ltd.

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.51.2

x